ロード中...
Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment
Alzheimer disease (AD) is a devastating disease and a global health problem, and current treatments are only symptomatic. A wealth of clinical studies support that the disease starts to develop decades before the first symptoms appear, emphasizing the importance of studying early changes for improvi...
保存先:
| 出版年: | FEBS J |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7496940/ https://ncbi.nlm.nih.gov/pubmed/31889402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15197 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|